7.25
price down icon4.35%   -0.33
after-market アフターアワーズ: 7.23 -0.02 -0.28%
loading
前日終値:
$7.58
開ける:
$7.4
24時間の取引高:
565.24K
Relative Volume:
1.03
時価総額:
$206.00M
収益:
$157.75M
当期純損益:
$-29.73M
株価収益率:
-6.25
EPS:
-1.16
ネットキャッシュフロー:
$-21.00M
1週間 パフォーマンス:
-12.86%
1か月 パフォーマンス:
+3.28%
6か月 パフォーマンス:
-59.38%
1年 パフォーマンス:
-54.83%
1日の値動き範囲:
Value
$7.115
$7.54
1週間の範囲:
Value
$6.79
$8.4766
52週間の値動き範囲:
Value
$5.85
$24.17

Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile

Name
名前
Arcturus Therapeutics Holdings Inc
Name
セクター
Healthcare (1108)
Name
電話
(858) 900-2660
Name
住所
10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Name
職員
176
Name
Twitter
@ArcturusRx
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
ARCT's Discussions on Twitter

Compare ARCT vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ARCT
Arcturus Therapeutics Holdings Inc
7.25 215.38M 157.75M -29.73M -21.00M -1.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.82 121.40B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
764.93 83.25B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
728.11 46.39B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.51 43.41B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
292.94 33.09B 5.36B 287.73M 924.18M 2.5229

Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-23 開始されました Roth Capital Buy
2025-10-24 ダウングレード H.C. Wainwright Buy → Neutral
2025-10-23 ダウングレード Citigroup Buy → Neutral
2025-10-22 ダウングレード Guggenheim Buy → Neutral
2025-09-04 再開されました H.C. Wainwright Buy
2025-05-28 開始されました Scotiabank Sector Outperform
2025-01-28 開始されました BTIG Research Buy
2024-08-12 開始されました Leerink Partners Outperform
2023-12-13 開始されました Canaccord Genuity Buy
2023-07-24 開始されました William Blair Outperform
2023-05-11 アップグレード H.C. Wainwright Neutral → Buy
2022-11-14 再開されました Wells Fargo Overweight
2022-11-10 ダウングレード Robert W. Baird Neutral → Underperform
2022-11-03 アップグレード Citigroup Neutral → Buy
2022-11-02 アップグレード Barclays Underweight → Equal Weight
2022-08-10 ダウングレード Raymond James Mkt Perform → Underperform
2022-07-19 再開されました Cantor Fitzgerald Overweight
2022-05-11 アップグレード Robert W. Baird Underperform → Neutral
2022-04-21 ダウングレード Citigroup Buy → Neutral
2022-01-31 アップグレード Raymond James Underperform → Mkt Perform
2021-08-12 ダウングレード Raymond James Mkt Perform → Underperform
2021-08-11 ダウングレード Goldman Neutral → Sell
2021-08-10 ダウングレード Robert W. Baird Neutral → Underperform
2021-07-02 開始されました Cantor Fitzgerald Overweight
2021-06-25 再開されました Goldman Neutral
2021-06-21 ダウングレード Barclays Equal Weight → Underweight
2021-06-04 再開されました Robert W. Baird Neutral
2021-02-17 ダウングレード B. Riley Securities Neutral → Sell
2021-01-19 ダウングレード B. Riley Securities Buy → Neutral
2021-01-15 ダウングレード B. Riley Securities Buy → Neutral
2021-01-07 開始されました Wells Fargo Overweight
2020-12-29 ダウングレード Barclays Overweight → Equal Weight
2020-12-29 ダウングレード H.C. Wainwright Buy → Neutral
2020-12-29 ダウングレード Raymond James Outperform → Mkt Perform
2020-12-29 ダウングレード Robert W. Baird Outperform → Neutral
2020-12-23 ダウングレード ROTH Capital Buy → Sell
2020-12-08 繰り返されました B. Riley Securities Buy
2020-12-07 繰り返されました B. Riley Securities Buy
2020-10-26 開始されました Barclays Overweight
2020-10-06 開始されました Citigroup Buy
2020-08-26 開始されました Piper Sandler Overweight
2020-07-30 再開されました ROTH Capital Buy
2020-07-16 開始されました Raymond James Outperform
2020-07-13 開始されました B. Riley FBR Buy
2020-06-09 ダウングレード WBB Securities Buy → Hold
2020-02-11 開始されました Robert W. Baird Outperform
2020-02-07 開始されました Guggenheim Buy
2020-02-06 開始されました Guggenheim Buy
2019-04-05 開始されました H.C. Wainwright Buy
2018-09-20 アップグレード WBB Securities Buy → Strong Buy
2018-01-22 開始されました Chardan Capital Markets Buy
すべてを表示

Arcturus Therapeutics Holdings Inc (ARCT) 最新ニュース

pulisher
05:01 AM

Demystifying Arcturus Therapeutics: Insights From 4 Analyst Reviews - Benzinga

05:01 AM
pulisher
04:55 AM

Citigroup Lowers Price Target for Arcturus Therapeutics (ARCT) to $21 | ARCT Stock News - GuruFocus

04:55 AM
pulisher
03:55 AM

Citigroup Issues Pessimistic Forecast for Arcturus Therapeutics (NASDAQ:ARCT) Stock Price - MarketBeat

03:55 AM
pulisher
12:01 PM

Arcturus Therapeutics to Attend Upcoming Investor Conference - PharmiWeb.com

12:01 PM
pulisher
09:00 AM

mRNA drug developer Arcturus set for Leerink healthcare fireside chat - Stock Titan

09:00 AM
pulisher
08:09 AM

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2025 Earnings Call Transcript - Insider Monkey

08:09 AM
pulisher
03:38 AM

ARK Investment Management LLC Boosts Position in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat

03:38 AM
pulisher
03:07 AM

Piper Sandler Maintains Overweight on Arcturus Therapeutics (ARCT) March 2026 - Meyka

03:07 AM
pulisher
Mar 04, 2026

Gossamer Bio, Seralutinib Misses Tight Statistical Mark But Shows Heart In High-Risk Lung Disease Study - AOL.com

Mar 04, 2026
pulisher
Mar 04, 2026

Arcturus Therapeutics Holdings ARCT Q4 Revenue Slide To US$7.2 Million Tests Growth Narrative - simplywall.st

Mar 04, 2026
pulisher
Mar 04, 2026

Arcturus Therapeutics Holdings Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 04, 2026
pulisher
Mar 04, 2026

Citigroup Issues Positive Forecast for Arcturus Therapeutics (NASDAQ:ARCT) Stock Price - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Citigroup Raises Price Target for Arcturus Therapeutics (ARCT) t - GuruFocus

Mar 04, 2026
pulisher
Mar 04, 2026

Piper Sandler Lowers Price Target for Arcturus Therapeutics (ARC - GuruFocus

Mar 04, 2026
pulisher
Mar 04, 2026

New nasal vaccine protects lungs for months against viruses, bacteria, and allergens - AOL.com

Mar 04, 2026
pulisher
Mar 04, 2026

Piper Sandler Cuts Arcturus Therapeutics (NASDAQ:ARCT) Price Target to $25.00 - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Arcturus Therapeutics reports financial results and pipeline progress - Traders Union

Mar 04, 2026
pulisher
Mar 04, 2026

Arcturus Therapeutics Holdings Inc (ARCT) Q4 2025 Earnings Call - GuruFocus

Mar 04, 2026
pulisher
Mar 03, 2026

Arcturus Therapeutics Q4 2025 Earnings Call Transcript - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

Earnings call transcript: Arcturus Q4 2025 misses expectations, stock drops - Investing.com South Africa

Mar 03, 2026
pulisher
Mar 03, 2026

Arcturus Therapeutics Q4 Earnings Call Highlights - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

ARCTURUS THERAPEUTICS ($ARCT) Releases Q4 2025 Earnings - Quiver Quantitative

Mar 03, 2026
pulisher
Mar 03, 2026

Arcturus (ARCT) Faces Shortfall in Q4 Revenue, Focuses on New Th - GuruFocus

Mar 03, 2026
pulisher
Mar 03, 2026

Arcturus Therapeutics Holdings Inc earnings missed by $5.31, revenue fell short of estimates By Investing.com - Investing.com Canada

Mar 03, 2026
pulisher
Mar 03, 2026

Arcturus Therapeutics Holdings Inc earnings missed by $5.31, revenue fell short of estimates - Investing.com Canada

Mar 03, 2026
pulisher
Mar 03, 2026

Arcturus Therapeutics (NASDAQ:ARCT) Releases Earnings Results, Misses Estimates By $0.11 EPS - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Mar 03, 2026
pulisher
Mar 03, 2026

Arcturus Therapeutics Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 03, 2026
pulisher
Mar 03, 2026

Arcturus Therapeutics falls 5% on weak quarterly revenue By Investing.com - Investing.com Nigeria

Mar 03, 2026
pulisher
Mar 03, 2026

Arcturus Therapeutics falls 5% on weak quarterly revenue - Investing.com South Africa

Mar 03, 2026
pulisher
Mar 03, 2026

Arcturus Therapeutics 10-K: Revenue $82.0M; EPS not reported - TradingView

Mar 03, 2026
pulisher
Mar 03, 2026

KOSTAIVE setback and mRNA pipeline progress at Arcturus (NASDAQ: ARCT) - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Arcturus Therapeutics (ARCT) trims 2025 loss and extends cash runway into Q2 2028 - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Arcturus Therapeutics Q4 Earnings Assessment - Benzinga

Mar 03, 2026
pulisher
Mar 03, 2026

Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress - Yahoo Finance

Mar 03, 2026
pulisher
Mar 03, 2026

Philadelphia College of Osteopathic Medicine cuts ribbon on renovated Student Success Center - AOL.com

Mar 03, 2026
pulisher
Mar 02, 2026

Precision Trading with Arcturus Therapeutics Holdings Inc. (ARCT) Risk Zones - Stock Traders Daily

Mar 02, 2026
pulisher
Mar 02, 2026

What To Expect From Arcturus Therapeutics Holdings Inc (ARCT) Q4 2025 Earnings - GuruFocus

Mar 02, 2026
pulisher
Mar 02, 2026

Earnings Preview: Arcturus Therapeutics - Sahm

Mar 02, 2026
pulisher
Feb 28, 2026

Momentum Shift: How liquid is Arcturus Therapeutics Holdings Inc stockJuly 2025 Weekly Recap & Real-Time Buy Signal Notifications - baoquankhu1.vn

Feb 28, 2026
pulisher
Feb 28, 2026

Bethany Children's Health Center unveils immersive experience plans - AOL.com

Feb 28, 2026
pulisher
Feb 27, 2026

Arcturus Therapeutics Holdings Inc expected to post a loss of 71 cents a shareEarnings Preview - TradingView

Feb 27, 2026
pulisher
Feb 26, 2026

Arcturus Therapeutics (ARCT) Stock Analysis: Exploring a 304% Potential Upside Amidst Clinical Pipeline Advances - DirectorsTalk Interviews

Feb 26, 2026
pulisher
Feb 24, 2026

Arcturus Therapeutics (ARCT) Expected to Post Earnings on Tuesday - MarketBeat

Feb 24, 2026
pulisher
Feb 20, 2026

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A Potential 346% Upside with Innovative mRNA Therapies - DirectorsTalk Interviews

Feb 20, 2026
pulisher
Feb 19, 2026

Technical Reactions to ARCT Trends in Macro Strategies - Stock Traders Daily

Feb 19, 2026
pulisher
Feb 19, 2026

Roth Capital Say Market Pricing Implies Zero Success for Arcturus Therapeutics Holdings Inc. (ARCT) Pipeline Assets - MSN

Feb 19, 2026
pulisher
Feb 19, 2026

Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Crosses Below Two Hundred Day Moving AverageWhat's Next? - MarketBeat

Feb 19, 2026
pulisher
Feb 18, 2026

Volatility Watch: How is Arcturus Therapeutics Holdings Inc managing supply chain issuesMarket Growth Report & Verified Momentum Stock Watchlist - baoquankhu1.vn

Feb 18, 2026
pulisher
Feb 18, 2026

Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026 - BioSpace

Feb 18, 2026
pulisher
Feb 17, 2026

Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Co - PharmiWeb.com

Feb 17, 2026

Arcturus Therapeutics Holdings Inc (ARCT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
大文字化:     |  ボリューム (24 時間):